Quartette

Product Category

US FDA-Approved Medicine

Formulation

ETHINYL ESTRADIOL: 0.2 mg, 0.025 mg, 0.03 mg, 0.01 mg LEVONORGESTREL: 0.15 mg, 0.15 mg, 0.15 mg, N/A 91 Oral Tablets: 42 tablets containing 0.15 mg levonorgestrel and 0.02 mg ethinyl estradiol (inactive ingredients = anhydrous lactose, D&C Red no. 27/phloxine aluminum lake, FD&C Blue no 2./Indigo Carmine aluminum lake, FD&C yellow no. 6/sunset yellow FCF aluminum lake, hypromellose, lactose monohydrate, microcrystalline cellulose, magnesium stearate, polyethylene glycol, macrogol, titanium dioxide, triacetin); 21 tablets containing 0.15 mg levonorgestrel and 0.025 mg ethinyl estradiol (inactive ingredients = anhydrous lactose, D&C Red no. 27/phloxine aluminum lake, FD&C blue no. 2/indigo carmine aluminum lake, hypromellose, lactose monohydrate, microcrystalline cellulose, magnesium stearate, polyethylene glycol/macrogol, titanium dioxide and triacetin); 21 tablets containing 0.15 mg levonorgestral and 0.02 mg ethinyl estradiol (inactive ingredients = anhydrous lactose, D&C Red no. 27/phloxine aluminum lake, FD&C blue no. 1/brilliant blue FCF aluminum lake, hypromellose, D&C red no. 27/phloxine aluminum lake, hypromellose, lactose monohydrate, microcrystalline cellulose, magnesium stearate, polyethylene glycol/macrogol, titanium dioxide, triacetin); 7 tablets containing 0.01 mg ethinyl estradiol (inactive ingredients = anhydrous lactose, D&C yellow no. 10 aluminum lake, FD&C yellow no. 6/sunset yellow FCF aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polacrilin potassium, polyethylene glycol/macrogol, polysorbate 80 and titanium dioxide)

Status

Prescription

ANDA #

204061

Manufacturers